1. Laboratory of Neuroimmunovirology, Human Health Research Center, INRS-Armand-Frappier Institute, University of Quebec, Laval, Québec, Canada H7V 1B71;
2. Department of Pharmacology, University of Sherbrooke, Sherbrooke, Québec, Canada J1H 5N42; and
3. NeuroResource, Institute of Neurology, University College London, London WC1N 1PJ, England3